Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

ConditionAcute Coronary Syndromes

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-65

SponsorKing Edward Medical University

About this trial

there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Rosuvastatin 20 mg/day
Atorvastatin 40 mg

Treatment groups

152 Participants

are divided into 2 treatment groups

Sponsors and collaborators

King Edward Medical University

Lead sponsor

Source ClinicalTrials.gov